IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE

Area of Science:

• Health Economics and Outcomes Research (HEOR)
• Pharmaceutical Market Access
• Health Technology Assessment (HTA)

Background:

• The HTA Core Model® was developed to enhance the transferability of health technology assessment (HTA) across different settings.
• It is of interest to HTA agencies and pharmaceutical manufacturers for evidence generation and stakeholder communication.

Purpose of the Study:

• To assess the fitness of the HTA Core Model® for purpose from an industry perspective.
• To evaluate the model's usefulness in meeting payer evidence needs and demonstrating pharmaceutical value.

Main Methods:

• A questionnaire surveyed country affiliate teams on the usefulness of HTA Core Model v2.0 elements.
• Survey results were refined through workshops to ensure consistency and alignment among teams.
• The assessment focused on evidence generation and reimbursement submissions for pharmaceuticals.

Main Results:

• Six country affiliate teams completed the questionnaire; a global pricing and market access team participated in workshops.
• Key model domains identified as most important include health problem, technology description, clinical effectiveness, and economic value.
• The model was found useful for efficient HTA evidence generation, internal evidence sharing, and communicating value to payers.

Conclusions:

• The HTA Core Model® offers a useful industry framework and common terminology for generating transferable HTA evidence efficiently.
• Standardization of HTA processes across settings can improve timeliness, efficiency, and transparency.